Jane Street
CLRB icon

Jane Street’s Cellectar Biosciences CLRB Stock Holding History

Jane Street’s Portfolio CLRB Stock Details CLRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,396
Closed -$105K – 9641
2024
Q2 		$105K Sell
1,396
-585
-30% -$56.1K ﹤0.01% 8711
2024
Q1 		$236K Buy
+1,981
New +$215K ﹤0.01% 7931
2022
Q3 		– Sell
-45
Closed -$5K – 9768
2022
Q2 		$5K Buy
+45
New +$6.43K ﹤0.01% 9413
2022
Q1 		– Sell
-47
Closed -$9K – 10350
2021
Q4 		$9K Buy
+47
New +$11.3K ﹤0.01% 9911

Other funds holding CLRB

RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Jane Street's CLRB Position: Q3 2024 in Review

Jane Street sold out of Cellectar Biosciences (CLRB) in Q3 2024, closing a stake of 1,396 shares — an estimated $105K sold.

Jane Street first reported a position in CLRB in Q4 2021 and held it in 4 quarters. The position peaked at $236K in Q1 2024. 35 funds tracked by Wall St. Rank hold CLRB as of Q3 2024.

  • Jane Street reported no remaining Cellectar Biosciences position as of Q3 2024 after selling out during the quarter.
  • Jane Street sold 1,396 Cellectar Biosciences shares in Q3 2024, an estimated $105K.
  • Jane Street first reported a position in Cellectar Biosciences in Q4 2021 and held it in 4 quarters.
  • Jane Street's Cellectar Biosciences position peaked at $236K in Q1 2024.
  • 35 funds tracked by Wall St. Rank held Cellectar Biosciences as of Q3 2024.

Based on Jane Street's 13F filing for Q3 2024, filed 15 Nov 2024.